MRE11 and cancer: Further structural modification of Mirin resulted in PFM01 and PFM03 as selective endonuclease inhibitors and PFM39 which selectively block the exonuclease activity of MRE11 (Figure 8), while their potential function in cancer therapy remains poorly explored (133).